300765SZSE

Announcement on the 2026 Salary Plan for Directors and Senior Management

✨ AI Summary

This announcement details the 2026 salary plan for directors and senior management of Shiyao Innovation Pharmaceutical Co., Ltd. The plan includes basic and performance-based salaries for non-independent directors and senior management, with performance pay comprising at least 50%. Independent directors will receive a fixed annual allowance of 80,000 RMB.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 300765 Stock Abbreviation: Xin Nuo Wei Announcement Number: 2026-023

Shiyao Innovation Pharmaceutical Co., Ltd. Announcement on the 2026 Salary Plan for Directors and Senior Management

The Company and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

Shiyao Innovation Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 32nd meeting of the Sixth Board of Directors on March 16, 2026, and deliberated on the "Proposal on the 2026 Salary Plan for Directors and Senior Management of the Company." Given that this proposal involves the remuneration of directors themselves, all directors abstained from voting. This proposal still needs to be submitted to the Company's shareholders' meeting for deliberation. The Company's proposed 2026 salary plan for directors and senior management is as follows:

I. Scope of Application of this Plan Company directors and senior management.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.